Corteva (NYSE:CTVA) Issues FY 2026 Earnings Guidance

Corteva (NYSE:CTVA) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 3.600-3.800 for the period, compared to the consensus EPS estimate of 3.740. The company issued revenue guidance of -, compared to the consensus revenue estimate of $18.3 billion.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on CTVA. BNP Paribas Exane raised their price target on shares of Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Barclays boosted their price objective on shares of Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a research note on Thursday, June 11th. The Goldman Sachs Group raised their target price on Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th. Rothschild & Co Redburn lifted their target price on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Finally, Wells Fargo & Company upped their price target on Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday, April 21st. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $90.19.

Corteva Trading Down 1.2%

Shares of NYSE:CTVA traded down $1.12 during trading on Thursday, reaching $89.39. The stock had a trading volume of 5,561,841 shares, compared to its average volume of 3,166,264. The firm’s fifty day moving average is $82.16 and its 200 day moving average is $79.55. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. Corteva has a 52 week low of $60.53 and a 52 week high of $90.97. The stock has a market cap of $59.79 billion, a price-to-earnings ratio of 52.58, a P/E/G ratio of 2.74 and a beta of 0.56.

Corteva (NYSE:CTVA) last announced its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. During the same quarter last year, the firm earned $2.20 earnings per share. Corteva’s quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities analysts forecast that Corteva will post 3.76 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is presently 42.35%.

More Corteva News

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Quarterly earnings exceeded expectations: Corteva reported second-quarter EPS of $2.30, above the $2.24 consensus estimate and up from $2.20 a year earlier. Corteva Q2 Earnings Beat Estimates
• Positive Sentiment: Full-year outlook was raised: Management increased its 2026 EPS guidance to $3.60-$3.80, reflecting strong first-half performance, cost controls and growth from strategic platforms. The midpoint is broadly consistent with analyst expectations. Corteva Delivers Strong First Half and Raises Outlook
• Positive Sentiment: Growth initiatives remain supportive: Demand for newer seed germplasm, trait technologies and crop-protection products, along with licensing growth and operational improvements, helped offset competitive pricing pressure. Corteva also remains on schedule for the planned October 1 Vylor spin-off. Why Corteva’s Seed and Crop Protection Engines Matter
• Neutral Sentiment: Separation could reshape the investment story: Corteva’s innovation pipeline, including crop-protection products and royalty opportunities, may support future growth after the planned business split, although the benefits will depend on execution. Corteva’s Innovation Pipeline
• Negative Sentiment: Revenue missed expectations: Second-quarter revenue was $6.38 billion, below the $6.60 billion analyst estimate, and declined 1.2% year over year. Competitive pricing remains a concern. Corteva Earnings Press Release
• Negative Sentiment: Valuation and execution risks are elevated: After a powerful rally, CTVA trades near its 52-week high at a premium earnings multiple. Investors may remain cautious about separation costs, execution risk and whether growth can justify the valuation. Is CTVA Stock Worth Buying After Its Rally?

Institutional Investors Weigh In On Corteva

Several institutional investors and hedge funds have recently made changes to their positions in the business. JPL Wealth Management LLC acquired a new position in Corteva in the third quarter valued at approximately $25,000. Garton & Associates Financial Advisors LLC acquired a new stake in shares of Corteva during the 4th quarter worth approximately $27,000. Bank of Jackson Hole Trust acquired a new stake in shares of Corteva during the 4th quarter worth approximately $28,000. Measured Wealth Private Client Group LLC bought a new stake in shares of Corteva in the 3rd quarter valued at $33,000. Finally, Binnacle Investments Inc increased its stake in shares of Corteva by 54.7% in the 2nd quarter. Binnacle Investments Inc now owns 512 shares of the company’s stock valued at $38,000 after acquiring an additional 181 shares in the last quarter. Institutional investors own 81.54% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.